Breaking News Instant updates and real-time market news.

$NYE

NYSE Market Internals

/

+

16:16
07/26/21
07/26
16:16
07/26/21
16:16

NYSE market internals summary

Volume was above average for this time of day. Breadth was bullish across the board. Advancing Issues: 1865 / Declining Issues: 1452 -- for a ratio of 1.3 to 1. Advancing Volume: 2,163,849,000 / Declining Volume: 1,927,563,000 -- for a ratio of 1.1 to 1. New 52-Week Highs: 124 / New 52-Week Lows: 69.

TODAY'S FREE FLY STORIES

Hot Stocks
Bristol-Myers: FDA accepts priority review for relatlimab/nivolumab BLA » 07:01
09/20/21
09/20
07:01
09/20/21
07:01
BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

Bristol Myers Squibb…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

Recommendations
Las Vegas Sands price target lowered to $42 from $53 at Morgan Stanley » 07:00
09/20/21
09/20
07:00
09/20/21
07:00
LVS

Las Vegas Sands

$38.17 /

+0.66 (+1.76%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 Jefferies
Jefferies downgrades Las Vegas Sands on 'growth uncertainty' in Macau
09/17/21 Jefferies
Las Vegas Sands downgraded to Hold from Buy at Jefferies
09/16/21 JPMorgan
JPMorgan downgrades Las Vegas Sands on Macau uncertainty
LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

Recommendations
Morgan Stanley cuts Wynn Resorts price target to $113, but says 'worth the risk' » 06:59
09/20/21
09/20
06:59
09/20/21
06:59
WYNN

Wynn Resorts

$83.30 /

-1.095 (-1.30%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/16/21 JPMorgan
Wynn Resorts downgraded on Macau uncertainty at JPMorgan
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

  • 09
    Feb
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

Upgrade
Methanex upgraded to Outperform from Sector Perform at Scotiabank » 06:58
09/20/21
09/20
06:58
09/20/21
06:58
MEOH

Methanex

$42.90 /

+1.3 (+3.13%)

Scotiabank analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEOH Methanex
$42.90 /

+1.3 (+3.13%)

MEOH Methanex
$42.90 /

+1.3 (+3.13%)

09/13/21 Piper Sandler
Methanex initiated with a Neutral at Piper Sandler
09/07/21 Barclays
Methanex upgraded to Overweight from Equal Weight at Barclays
09/01/21 RBC Capital
Methanex to generate strong cash flows in 2021-22, says RBC Capital
07/19/21 TD Securities
Methanex price target raised to $54 from $51 at TD Securities
MEOH Methanex
$42.90 /

+1.3 (+3.13%)

Hot Stocks
PyroGenesis joins two FTSE Russell Indexes » 06:58
09/20/21
09/20
06:58
09/20/21
06:58
PYR

PyroGenesis

$4.42 /

+0.1 (+2.31%)

PyroGenesis Canada is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

Hot Stocks
Materion to acquire H.C. Starck's Electronic Materials portfolio » 06:57
09/20/21
09/20
06:57
09/20/21
06:57
MTRN

Materion

$71.29 /

+1.01 (+1.44%)

Materion Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTRN Materion
$71.29 /

+1.01 (+1.44%)

MTRN Materion
$71.29 /

+1.01 (+1.44%)

08/09/21 KeyBanc
Materion downgraded to Sector Weight from Overweight at KeyBanc
05/06/21 Sidoti
Materion reinstated with a Buy at Sidoti
01/26/21 KeyBanc
Materion price target raised to $80 from $68 at KeyBanc
MTRN Materion
$71.29 /

+1.01 (+1.44%)

Initiation
Workday initiated with an Overweight at Wells Fargo » 06:56
09/20/21
09/20
06:56
09/20/21
06:56
WDAY

Workday

$268.56 /

-2.37 (-0.87%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDAY Workday
$268.56 /

-2.37 (-0.87%)

WDAY Workday
$268.56 /

-2.37 (-0.87%)

09/17/21 Barclays
Workday price target raised to $340 from $309 at Barclays
09/09/21 Exane BNP Paribas
Workday upgraded to Outperform from Neutral at Exane BNP Paribas
09/02/21 Jefferies
Workday price target raised to $320 from $300 at Jefferies
09/01/21 Goldman Sachs
Anaplan price target raised to $67 from $59 at Goldman Sachs
WDAY Workday
$268.56 /

-2.37 (-0.87%)

WDAY Workday
$268.56 /

-2.37 (-0.87%)

WDAY Workday
$268.56 /

-2.37 (-0.87%)

WDAY Workday
$268.56 /

-2.37 (-0.87%)

Hot Stocks
CareMax appoints Beatriz Assapimonwait to board of directors » 06:55
09/20/21
09/20
06:55
09/20/21
06:55
CMAX

CareMax

$9.50 /

-0.05 (-0.52%)

CareMax announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMAX CareMax
$9.50 /

-0.05 (-0.52%)

CMAX CareMax
$9.50 /

-0.05 (-0.52%)

09/13/21
Fly Intel: Top five analyst upgrades
09/13/21 Piper Sandler
CareMax upgraded to Overweight from Neutral at Piper Sandler
09/09/21 Cowen
CareMax initiated with an Outperform at Cowen
07/01/21
Fly Intel: Top five analyst initiations
CMAX CareMax
$9.50 /

-0.05 (-0.52%)

General news
FX Update: The dollar and yen have rallied amid acute risk-off positioning » 06:55
09/20/21
09/20
06:55
09/20/21
06:55
$ECON

Economic Data

/

+

FX Update: The dollar and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Initiation
Salesforce initiated with an Overweight at Wells Fargo » 06:54
09/20/21
09/20
06:54
09/20/21
06:54
CRM

Salesforce

$260.52 /

+0.13 (+0.05%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$260.52 /

+0.13 (+0.05%)

CRM Salesforce
$260.52 /

+0.13 (+0.05%)

09/17/21 Barclays
Salesforce price target raised to $330 from $320 at Barclays
08/27/21 Loop Capital
Salesforce price target raised to $265 from $235 at Loop Capital
08/27/21 Societe Generale
Salesforce price target raised to $321 from $290 at Societe Generale
08/26/21 RBC Capital
Salesforce assumed with an Outperform at RBC Capital
CRM Salesforce
$260.52 /

+0.13 (+0.05%)

CRM Salesforce
$260.52 /

+0.13 (+0.05%)

CRM Salesforce
$260.52 /

+0.13 (+0.05%)

CRM Salesforce
$260.52 /

+0.13 (+0.05%)

Initiation
Adobe initiated with an Overweight at Wells Fargo » 06:52
09/20/21
09/20
06:52
09/20/21
06:52
ADBE

Adobe

$655.09 /

-10.26 (-1.54%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

06:26 Today Citi
Adobe shares may be pricing in front office tailwinds, says Citi
09/17/21 Mizuho
Adobe price target raised to $695 from $640 at Mizuho
09/16/21 BMO Capital
Adobe price target raised to $730 from $630 at BMO Capital
09/16/21 Barclays
Adobe price target raised to $740 from $660 at Barclays
ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

Hot Stocks
Independence Contract Drilling signs drilling contract to reactivate 16th rig » 06:50
09/20/21
09/20
06:50
09/20/21
06:50
ICD

Independence Contract Drilling

$2.74 /

-0.02 (-0.72%)

Independence Contract…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
    Hot Stocks
    Bridge Specialty Group announces asset acquisition of Gremesco of New Jersey » 06:48
    09/20/21
    09/20
    06:48
    09/20/21
    06:48
    BRO

    Brown & Brown

    $56.96 /

    -0.495 (-0.86%)

    Brown & Brown and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    08/16/21 Wolfe Research
    Brown & Brown initiated with a Peer Perform at Wolfe Research
    07/27/21 Keefe Bruyette
    Keefe Bruyette boosts Brown & Brown target on 'stronger' organic growth
    04/28/21 Deutsche Bank
    Brown & Brown price target raised to $55 from $50 at Deutsche Bank
    04/28/21 RBC Capital
    Brown & Brown price target raised to $53 from $48 at RBC Capital
    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    Hot Stocks
    Pfizer, BioNTech announce results from trial of COVID-19 vaccine in children » 06:47
    09/20/21
    09/20
    06:47
    09/20/21
    06:47
    PFE

    Pfizer

    $43.89 /

    -0.57 (-1.28%)

    , BNTX

    BioNTech

    $358.75 /

    -13.75 (-3.69%)

    Pfizer Inc. (PFE) and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    06:31 Today Citi
    Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
    09/17/21 Evercore ISI
    Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
    09/16/21 Canaccord
    Exact Sciences salesforce expansion a net positive, says Canaccord
    09/16/21 BofA
    Moderna boosters already reflected in 'bullish' consensus, says BofA
    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    09/17/21 Evercore ISI
    Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
    08/27/21 UBS
    BioNTech price target raised to $300 from $111 at UBS
    08/20/21 Canaccord
    BioNTech price target raised to $450 from $240 at Canaccord
    08/12/21 Wells Fargo
    Wells says Moderna vaccine looks more effective than Pfizer's against Delta
    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    Recommendations
    Molina Healthcare price target raised to $305 from $284 at Mizuho » 06:45
    09/20/21
    09/20
    06:45
    09/20/21
    06:45
    MOH

    Molina Healthcare

    $278.12 /

    +8.09 (+3.00%)

    Mizuho analyst Ann Hynes…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    09/09/21 Cowen
    Molina Healthcare initiated with an Outperform at Cowen
    09/08/21 Mizuho
    Selloff in managed care sector overdone, says Mizuho
    07/30/21 BMO Capital
    Molina Healthcare price target raised to $315 from $300 at BMO Capital
    07/30/21 Mizuho
    Molina Healthcare price target raised to $284 from $273 at Mizuho
    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    Recommendations
    Sale of Voyager more likely than out-licensing, says Benchmark » 06:45
    09/20/21
    09/20
    06:45
    09/20/21
    06:45
    VYGR

    Voyager Therapeutics

    $3.13 /

    +0.09 (+2.96%)

    Over the last two weeks…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    VYGR Voyager Therapeutics
    $3.13 /

    +0.09 (+2.96%)

    VYGR Voyager Therapeutics
    $3.13 /

    +0.09 (+2.96%)

    08/11/21 Benchmark
    Voyager Therapeutics price target lowered to $9 from $20 at Benchmark
    07/09/21 Chardan
    Voyager Therapeutics coverage transferred at Chardan
    05/20/21 Benchmark
    Voyager Therapeutics' 'three-point value' remains despite exits, says Benchmark
    04/26/21 Wedbush
    Wedbush sees FDA clearance of IND for VY-HTT01 as 'clear positive' for Voyager
    VYGR Voyager Therapeutics
    $3.13 /

    +0.09 (+2.96%)

    General news
    FX Action: USD-CAD lifted by over 0.5% in posting a one-month high » 06:45
    09/20/21
    09/20
    06:45
    09/20/21
    06:45
    $ECON

    Economic Data

    /

    +

    FX Action: USD-CAD lifted…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    $ECON Economic Data
    /

    +

    $ECON Economic Data
    /

    +

    Hot Stocks
    Aerie appoints Erik Pacyniak as director, toxicology, drug disposition » 06:39
    09/20/21
    09/20
    06:39
    09/20/21
    06:39
    AERI

    Aerie Pharmaceuticals

    $12.84 /

    +0.495 (+4.01%)

    Aerie Pharmaceuticals…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    AERI Aerie Pharmaceuticals
    $12.84 /

    +0.495 (+4.01%)

    AERI Aerie Pharmaceuticals
    $12.84 /

    +0.495 (+4.01%)

    11/09/20 H.C. Wainwright
    Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright
    10/28/20 H.C. Wainwright
    Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright
    10/19/20 BofA
    Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
    10/19/20 BofA
    Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
    AERI Aerie Pharmaceuticals
    $12.84 /

    +0.495 (+4.01%)

    AERI Aerie Pharmaceuticals
    $12.84 /

    +0.495 (+4.01%)

    Initiation
    Li-Cycle initiated with an Outperform at Wedbush » 06:39
    09/20/21
    09/20
    06:39
    09/20/21
    06:39
    LICY

    Li-Cycle

    $8.77 /

    +0.09 (+1.04%)

    Wedbush analyst Daniel…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    LICY Li-Cycle
    $8.77 /

    +0.09 (+1.04%)

    LICY Li-Cycle
    $8.77 /

    +0.09 (+1.04%)

    09/13/21 Morgan Stanley
    Li-Cycle initiated with an Overweight at Morgan Stanley
    09/09/21 BMO Capital
    Li-Cycle initiated with an Outperform at BMO Capital
    08/23/21 Baird
    Baird starts Li-Cycle at Neutral, sees 'discounted multiple' as warranted
    08/23/21 Baird
    Li-Cycle initiated with a Neutral at Baird
    LICY Li-Cycle
    $8.77 /

    +0.09 (+1.04%)

    LICY Li-Cycle
    $8.77 /

    +0.09 (+1.04%)

    LICY Li-Cycle
    $8.77 /

    +0.09 (+1.04%)

    Hot Stocks
    ChromaDex announces preclincal research findings from CERP » 06:38
    09/20/21
    09/20
    06:38
    09/20/21
    06:38
    CDXC

    ChromaDex

    $6.75 /

    +0.44 (+6.97%)

    ChromaDex announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CDXC ChromaDex
    $6.75 /

    +0.44 (+6.97%)

    CDXC ChromaDex
    $6.75 /

    +0.44 (+6.97%)

    08/04/21 H.C. Wainwright
    ChromaDex price target raised to $12 from $11 at H.C. Wainwright
    06/07/21 H.C. Wainwright
    ChromaDex sales momentum should accelerate, says H.C. Wainwright
    03/16/21 H.C. Wainwright
    ChromaDex price target raised to $16 from $7 at H.C. Wainwright
    03/08/21 B. Riley Securities
    ChromaDex price target raised to $18 from $7 at B. Riley Securities
    CDXC ChromaDex
    $6.75 /

    +0.44 (+6.97%)

    CDXC ChromaDex
    $6.75 /

    +0.44 (+6.97%)

    CDXC ChromaDex
    $6.75 /

    +0.44 (+6.97%)

    Hot Stocks
    Sanofi reports Libtayo Phase 3 trial met primary, key secondary endpoints » 06:38
    09/20/21
    09/20
    06:38
    09/20/21
    06:38
    SNY

    Sanofi

    $48.35 /

    +0.14 (+0.29%)

    , REGN

    Regeneron

    $651.38 /

    -2.3 (-0.35%)

    Phase 3 results for…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    06:31 Today Citi
    Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
    09/14/21 Mizuho
    Kadmon downgraded to Neutral from Buy at Mizuho
    09/10/21 UBS
    Kadmon downgraded to Neutral from Buy at UBS
    09/09/21 RBC Capital
    Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    09/15/21 Cantor Fitzgerald
    Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
    09/15/21 H.C. Wainwright
    Regeneron price target raised to $831 from $787 at H.C. Wainwright
    09/15/21 Piper Sandler
    Regeneron price target raised to $690 from $675 at Piper Sandler
    09/09/21
    Fly Intel: Top five analyst initiations
    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    Hot Stocks
    Synlogic announces data from studies evaluating SYNB1618, SYNB1934 » 06:38
    09/20/21
    09/20
    06:38
    09/20/21
    06:38
    SYBX

    Synlogic

    $3.25 /

    +0.06 (+1.88%)

    Synlogic announced data…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    SYBX Synlogic
    $3.25 /

    +0.06 (+1.88%)

    SYBX Synlogic
    $3.25 /

    +0.06 (+1.88%)

    07/09/21 Chardan
    Synlogic assumed with a Buy at Chardan
    06/28/21 H.C. Wainwright
    Synlogic price target lowered to $9 from $13 at H.C. Wainwright
    03/25/21 SVB Leerink
    Synlogic price target raised to $15 from $10 at SVB Leerink
    03/18/21 JonesTrading
    Synlogic initiated with a Buy at JonesTrading
    SYBX Synlogic
    $3.25 /

    +0.06 (+1.88%)

    • 16
      Apr
    SYBX Synlogic
    $3.25 /

    +0.06 (+1.88%)

    Recommendations
    Personalis Veterans Affairs contract smaller than expected, says Citi » 06:37
    09/20/21
    09/20
    06:37
    09/20/21
    06:37
    PSNL

    Personalis

    $22.34 /

    +1.25 (+5.93%)

    Citi analyst Patrick…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    PSNL Personalis
    $22.34 /

    +1.25 (+5.93%)

    PSNL Personalis
    $22.34 /

    +1.25 (+5.93%)

    08/05/21 Citi
    Personalis price target lowered to $30 from $37 at Citi
    05/13/21 Truist
    Personalis price target lowered to $29 from $37 at Truist
    05/06/21 Oppenheimer
    Personalis upgraded to Outperform at Oppenheimer on multi-year growth cycle
    05/06/21 Oppenheimer
    Personalis upgraded to Outperform from Perform at Oppenheimer
    PSNL Personalis
    $22.34 /

    +1.25 (+5.93%)

    • 27
      Jan
    PSNL Personalis
    $22.34 /

    +1.25 (+5.93%)

    Hot Stocks
    Adagio Therapeutics expands patient population in EVADE Phase 2/3 trial » 06:36
    09/20/21
    09/20
    06:36
    09/20/21
    06:36
    ADGI

    Adagio Therapeutics

    $51.51 /

    -4.46 (-7.97%)

    The independent data…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ADGI Adagio Therapeutics
    $51.51 /

    -4.46 (-7.97%)

    08/31/21
    Fly Intel: Top five analyst initiations
    08/31/21 Guggenheim
    Adagio Therapeutics initiated with a Buy at Guggenheim
    08/31/21 Stifel
    Adagio Therapeutics initiated with a Buy at Stifel
    08/31/21 Jefferies
    Adagio Therapeutics initiated with a Buy at Jefferies
    ADGI Adagio Therapeutics
    $51.51 /

    -4.46 (-7.97%)

    • 06
      Aug
    ADGI Adagio Therapeutics
    $51.51 /

    -4.46 (-7.97%)

    General news
    Oil prices have dropped back » 06:35
    09/20/21
    09/20
    06:35
    09/20/21
    06:35
    $ECON

    Economic Data

    /

    +

    Oil prices have dropped…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    $ECON Economic Data
    /

    +

    $ECON Economic Data
    /

    +

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.